Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
International Journal of Pharmaceutics|January 1, 2019
The ocular pharmacokinetics and biodistribution of phospho-sulindac (OXT-328) formulated in nanoparticles: Enhanced and targeted tissue drug deliveryZiyi Wen, Natsuko Muratomi, Wei Huang, et al.
Plos One|November 5, 2010
Expression of versican 3'-untranslated region modulates endogenous microRNA functionsDaniel Y Lee, Zina Jeyapalan, Ling Fang, et al.
Plos One|October 22, 2009
MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7Shireen Kahai, Shao-Chen Lee, Daniel Y Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosisTheresa L Montgomery, Qin Wang, Ali Mirza, et al.
Current Radiopharmaceuticals|August 26, 2011
Biochemistry and biology of 2'-Fluoro-2'-deoxythymidine (FT), a putative highly selective substrate for thymidine kinase type 2 (TK2)Leonard I Wiebe, William Sun, Aihua Zhou, et al.
Urology Practice|June 14, 2023
Costs and Sustainability of a Behavioral Intervention for Urinary Incontinence PreventionTodd H Wagner, Jennifer Yang Scott, Diane K Newman, et al.
Current Radiopharmaceuticals|March 16, 2017
β -[18F]Fluoro Azomycin Arabinoside (β -[18F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 TumorsPiyush Kumar, Peter Roselt, Gerald Reischl, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2005
Water soluble prodrug of a COX-2 selective inhibitor suitable for intravenous administration in models of cerebral ischemiaNicholas D Smith, Thomas S Reger, Joseph Payne, et al.
Scientific Reports|July 3, 2024
Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosisTheresa L Montgomery, Qin Wang, Ali Mirza, et al.
Brain Sciences|May 25, 2024
Neuronavigated Right Orbitofrontal 20 Hz Theta Burst Transcranial Magnetic Stimulation Augmentation for Obsessive-Compulsive Disorder with Comorbid Depression and Anxiety Disorders: An Open-Label StudyWilliam F Stubbeman, Jennifer Yang, Julianne Converse, et al.
Pageof 14